Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers (2012)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.2174/138161212802884780
- Subjects: CANNABIS (EFEITOS); FARMACOLOGIA; ANSIEDADE
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Phamaceutical Design
- ISSN: 1873-4286
- Volume/Número/Paginação/Ano: v. 18, n. 32, p. 4966-4979, 2012
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
MARTÍN-SANTOS, R. et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, v. 18, n. 32, p. 4966-4979, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884780. Acesso em: 12 mar. 2026. -
APA
Martín-Santos, R., Crippa, J. A. de S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., et al. (2012). Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, 18( 32), 4966-4979. doi:10.2174/138161212802884780 -
NLM
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2026 mar. 12 ] Available from: https://doi.org/10.2174/138161212802884780 -
Vancouver
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2026 mar. 12 ] Available from: https://doi.org/10.2174/138161212802884780 - Induction of psychosis by Δ9- Tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience precessing
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of ''delta' POT.9'-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
- A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans
- Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats
- Uso de maconha e ansiedade
- Distinct effects of 'delta'9-Tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
- Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
- Modulation of effective connectivity during emotional processing by ''DELTA' POT.9'-tetrahydrocannabinol and cannabidiol
- Duloxetine in the treatment of panic disorder
- Antidepressant-like and anxiolytic-like effects of Cannabidiol: a chemical compound of Cannabis sativa
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
